Trait centric view

1. Trait name:	Milk C14 index
   Ontology terms:	VT:0010303, LPT:0010303

   67 genes are associated with this trait, with QTL/association found

   • AGTPBP1: ATP/GTP binding carboxypeptidase 1
     evidenced by: QTL:33663; QTL:33791;
   • ALDH18A1: Aldehyde dehydrogenase 18 family member A1
     evidenced by: QTL:34112; QTL:34113; QTL:34134; QTL:34154; QTL:34155; QTL:34156; QTL:34166; QTL:34243;
   • ANGPT1: Angiopoietin 1
     evidenced by: QTL:34468; QTL:34469;
   • ANKS1B: Ankyrin repeat and sterile alpha motif domain containing 1B
     evidenced by: QTL:34768; QTL:34870; QTL:34980; QTL:35047; QTL:35048; QTL:35049;
   • ANO5: Anoctamin 4
     evidenced by: QTL:34415; QTL:34662; QTL:34678; QTL:34679; QTL:34680; QTL:34681; QTL:34682; QTL:34683; QTL:34686; QTL:34687; QTL:34688; QTL:34689; QTL:34690; QTL:34833; QTL:34847; QTL:34848; QTL:34871; QTL:34872; QTL:34873; QTL:34874; QTL:34875; QTL:34876; QTL:34877; QTL:34878; QTL:34879; QTL:34880; QTL:34881; QTL:34882; QTL:34883; QTL:34884; QTL:34885; QTL:34886; QTL:34887; QTL:34888; QTL:34889; QTL:34890; QTL:34891; QTL:34892; QTL:34893; QTL:34894;
   • ARHGAP19: Rho GTPase activating protein 19
     evidenced by: QTL:33669; QTL:33670; QTL:33671;
   • ATRNL1: Attractin like 1
     evidenced by: QTL:33346; QTL:33896;
   • BTAF1: B-TFIID TATA-box binding protein associated factor 1
     evidenced by: QTL:34512;
   • BTRC: Beta-transducin repeat containing
     evidenced by: QTL:32565; QTL:32842; QTL:32899; QTL:33047; QTL:33048; QTL:33049; QTL:33050; QTL:33051; QTL:33052; QTL:33053; QTL:33054; QTL:33055; QTL:33056; QTL:33057; QTL:33058; QTL:33059; QTL:33060; QTL:33061; QTL:33062; QTL:33131;
   • CARMIL1: Capping protein regulator and myosin 1 linker 1
     evidenced by: QTL:34849;
   • CFAP43: Cilia and flagella associated protein 43
     evidenced by: QTL:34227;
   • CHUK: Component of inhibitor of nuclear factor kappa B kinase complex
     evidenced by: QTL:178692; QTL:178727; QTL:33431; QTL:33454; QTL:33537; QTL:33640; QTL:33895; QTL:33921;
   • CNNM2: Cyclin and CBS domain divalent metal cation transport mediator 2
     evidenced by: QTL:32571; QTL:32617; QTL:32975; QTL:32976; QTL:32977; QTL:32978; QTL:32979; QTL:32980; QTL:32981; QTL:33257; QTL:33463; QTL:33907; QTL:34229; QTL:34397; QTL:34399; QTL:34519; QTL:34520; QTL:34521; QTL:34631; QTL:34670; QTL:34851;
   • COL17A1: Collagen type XVII alpha 1 chain
     evidenced by: QTL:34916; QTL:35080;
   • COL5A3: Collagen type V alpha 3 chain
     evidenced by: QTL:32633;
   • COX15: COX15, cytochrome c oxidase assembly homolog
     evidenced by: QTL:34171;
   • CPM: Carboxypeptidase M
     evidenced by: QTL:211714; QTL:264089;
   • CRTAC1: Cartilage acidic protein 1
     evidenced by: QTL:32620; QTL:32631; QTL:32988; QTL:33031; QTL:33113; QTL:33427; QTL:33428; QTL:33429; QTL:33455; QTL:33563; QTL:33683; QTL:33708; QTL:33726;
   • CWF19L1: CWF19 like cell cycle control factor 1
     evidenced by: QTL:33456;
   • DNMBP: Dynamin binding protein
     evidenced by: QTL:32952; QTL:32953; QTL:32967; QTL:33498; QTL:33525; QTL:34270;
   • DNTT: DNA nucleotidylexotransferase
     evidenced by: QTL:32624; QTL:34106; QTL:34110; QTL:34533;
   • ECHS1: Enoyl-CoA hydratase, short chain 1
     evidenced by: QTL:179093; QTL:179098; QTL:179103; QTL:179107; QTL:179114;
   • ENTPD7: Ectonucleoside triphosphate diphosphohydrolase 7
     evidenced by: QTL:33264; QTL:33852; QTL:34163;
   • FFAR4: Free fatty acid receptor 4
     evidenced by: QTL:33107; QTL:33108; QTL:33302; QTL:33924;
   • GOT1: Glutamic-oxaloacetic transaminase 1
     evidenced by: QTL:33580; QTL:33609; QTL:34577;
   • GRIA1: Glutamate ionotropic receptor AMPA type subunit 1
     evidenced by: QTL:33536; QTL:33578;
   • HELLS: Helicase, lymphoid specific
     evidenced by: QTL:35106; QTL:35107; QTL:35108; QTL:35109; QTL:35110;
   • HIF1AN: Hypoxia inducible factor 1 subunit alpha inhibitor
     evidenced by: QTL:32839; QTL:32840; QTL:32992;
   • HPS1: HPS1 biogenesis of lysosomal organelles complex 3 subunit 1
     evidenced by: QTL:34515; QTL:34537;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:34207; QTL:34209; QTL:34210; QTL:34211; QTL:34212; QTL:34213; QTL:34214; QTL:34262; QTL:34528; QTL:34751; QTL:34826; QTL:34827; QTL:34828; QTL:34829; QTL:34830; QTL:34831; QTL:35044;
   • LIPA: Lipase A, lysosomal acid, cholesterol esterase
     evidenced by: QTL:34866; QTL:34867; QTL:34906; QTL:34907; QTL:34976;
   • LIPJ: Lipase family member J
     evidenced by: QTL:169753; QTL:169758; QTL:169770; QTL:169774; QTL:169780;
   • LOC100138984: Mitochondrial import inner membrane translocase subunit Tim17-A pseudogene
     evidenced by: QTL:34038; QTL:34039; QTL:34040; QTL:34041;
   • LOC511498: Cytochrome P450, family 2, subfamily c
     evidenced by: QTL:33560; QTL:33744;
   • LOC616580: Cytochrome P450 2C42-like
     evidenced by: QTL:34850;
   • LOC784616: Synaptojanin-2-binding protein-like
     evidenced by: QTL:33684; QTL:33685; QTL:33686;
   • MARCHF5: Membrane associated ring-CH-type finger 5
     evidenced by: QTL:33478; QTL:33661;
   • MYOF: Myoferlin
     evidenced by: QTL:33457; QTL:34114; QTL:34319; QTL:34447; QTL:34734;
   • NDUFB8: NADH:ubiquinone oxidoreductase subunit B8
     evidenced by: QTL:33006;
   • NEURL1: Neuralized E3 ubiquitin protein ligase 1
     evidenced by: QTL:33192; QTL:33193;
   • NT5C2: 5'-nucleotidase, cytosolic II
     evidenced by: QTL:33756; QTL:33757; QTL:33758; QTL:34067; QTL:34068; QTL:34069; QTL:34159; QTL:34160; QTL:34161; QTL:34165; QTL:34183; QTL:34184;
   • OPALIN: Oligodendrocytic myelin paranodal and inner loop protein
     evidenced by: QTL:34093; QTL:34094; QTL:34095; QTL:34111;
   • PAX2: Paired box 2
     evidenced by: QTL:32828; QTL:33073; QTL:33074; QTL:33151; QTL:34128; QTL:34129;
   • PCDH15: Protocadherin related 15
     evidenced by: QTL:32651;
   • PDLIM1: PDZ and LIM domain 1
     evidenced by: QTL:33668; QTL:34115; QTL:34396;
   • PI4K2A: Phosphatidylinositol 4-kinase type 2 alpha
     evidenced by: QTL:33453; QTL:33458; QTL:33717;
   • PIK3AP1: Phosphoinositide-3-kinase adaptor protein 1
     evidenced by: QTL:33940; QTL:33984;
   • PKD2L1: Polycystin 2 like 1, transient receptor potential cation channel
     evidenced by: QTL:33443;
   • PLCE1: Phospholipase C, epsilon 1
     evidenced by: QTL:34195; QTL:34392; QTL:34393; QTL:34394; QTL:34395; QTL:34400; QTL:34401; QTL:34478; QTL:34479;
   • PRKG1: Protein kinase, cGMP-dependent, type I
     evidenced by: QTL:176501;
   • RBM47: RNA binding motif protein 47
     evidenced by: QTL:32652;
   • RNLS: Renalase, FAD dependent amine oxidase
     evidenced by: QTL:33297; QTL:33298; QTL:33299; QTL:33347; QTL:33426;
   • RRP12: Ribosomal RNA processing 12 homolog
     evidenced by: QTL:33260; QTL:33261; QTL:33269; QTL:33881;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:101333; QTL:101336; QTL:101340; QTL:101344; QTL:101348; QTL:101352; QTL:32801; QTL:32802; QTL:32803; QTL:32804; QTL:32805; QTL:32806; QTL:32826; QTL:34003; QTL:34004; QTL:34005; QTL:34006; QTL:34007; QTL:34009; QTL:34024;
   • SH3PXD2A: SH3 and PX domains 2A
     evidenced by: QTL:32613; QTL:32629; QTL:33132; QTL:33133; QTL:33134; QTL:33135; QTL:33136; QTL:33137; QTL:33138; QTL:33139; QTL:33140; QTL:33141; QTL:33142; QTL:33143; QTL:33144; QTL:34016; QTL:34017; QTL:34018; QTL:34019; QTL:34020; QTL:34021; QTL:34022; QTL:34023; QTL:34025; QTL:34026; QTL:34027; QTL:34031; QTL:34032; QTL:34033; QTL:34271;
   • SHOC2: SHOC2 leucine rich repeat scaffold protein
     evidenced by: QTL:34918;
   • SLC25A28: Solute carrier family 25 member 28
     evidenced by: QTL:34322;
   • SLIT1: Slit guidance ligand 1
     evidenced by: QTL:33930; QTL:34117; QTL:34118; QTL:34119; QTL:34120; QTL:34121; QTL:34122; QTL:34123; QTL:34124; QTL:34516;
   • SLK: STE20 like kinase
     evidenced by: QTL:32562; QTL:33256;
   • SORBS1: Sorbin and SH3 domain containing 1
     evidenced by: QTL:32612; QTL:32644; QTL:33748; QTL:33982; QTL:33995; QTL:34198; QTL:34216; QTL:34324; QTL:34341; QTL:34342; QTL:34343;
   • SORCS1: Sortilin related VPS10 domain containing receptor 1
     evidenced by: QTL:33452; QTL:33491; QTL:33641; QTL:33642; QTL:33709;
   • SORCS3: Sortilin-related VPS10 domain containing receptor 3
     evidenced by: QTL:32911; QTL:32954; QTL:32990; QTL:33262; QTL:33263; QTL:33349; QTL:33449; QTL:33450; QTL:33636; QTL:33637; QTL:33638; QTL:33647; QTL:33662; QTL:33792; QTL:33801; QTL:33802; QTL:33803; QTL:33882; QTL:33985; QTL:34527; QTL:34752; QTL:34917; QTL:35039; QTL:35043; QTL:35077; QTL:35078;
   • SREBF1: Sterol regulatory element binding transcription factor 1
     evidenced by: QTL:25321; QTL:25322;
   • SUFU: Suppressor of fused homolog (Drosophila)
     evidenced by: QTL:32896; QTL:32935; QTL:32973; QTL:33085; QTL:33119; QTL:33255; QTL:33258; QTL:33259; QTL:34316; QTL:34480;
   • TLL2: Tolloid-like 2
     evidenced by: QTL:34044; QTL:34116; QTL:34125; QTL:34126; QTL:34215; QTL:34224; QTL:34225; QTL:34258; QTL:34267; QTL:34268; QTL:34328; QTL:34329; QTL:34330; QTL:34331; QTL:34750; QTL:34912; QTL:34913; QTL:34914;
   • UNC13B: Unc-13 homolog B
     evidenced by: QTL:33676; QTL:33677; QTL:33678;
   • WBP1L: WW domain binding protein 1 like
     evidenced by: QTL:32606; QTL:32947; QTL:32948;